Related Experiment Video
Updated: Mar 22, 2026
09:40
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
3.3K
Abstract:
mTORC1 reprograms metabolism to promote cell survival following glycolytic block.
Insights
The mechanistic target of rapamycin complex 1 (mTORC1) pathway reprograms cellular metabolism to ensure survival when glycolysis is blocked. This metabolic reprogramming is crucial for cell survival under stress conditions.
Area of Science:
- Cellular metabolism
- Molecular signaling pathways
Background:
- Glycolytic inhibition triggers cellular stress.
- Cellular survival mechanisms are activated under metabolic stress.
Discussion:
- mTORC1 signaling is a key regulator of metabolic adaptation.
- Reprogramming of metabolic pathways is essential for overcoming glycolytic blockade.
- Cellular survival is contingent on adaptive metabolic changes.
Key Insights:
- mTORC1 orchestrates metabolic flux changes.
- Metabolic reprogramming by mTORC1 supports cell survival.
- Glycolytic block necessitates metabolic adaptation mediated by mTORC1.
Outlook:
- Further investigation into mTORC1-mediated metabolic control in disease.
- Therapeutic targeting of mTORC1 for metabolic disorders.
- Exploring downstream effectors of mTORC1 in metabolic adaptation.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K
03:03mTOR Signaling and Cancer Progression
1.6K
1.6K
02:53Adaptive Mechanisms in Cancer Cells
7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
02:53Adaptive Mechanisms in Cancer Cells
4.2K
4.2K
01:22PI3K/mTOR/AKT Signaling Pathway
6.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.2K
01:46Electron Transport Chain: Complex I and II
19.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.5K